Arcus Biosciences Inc (RCUS)
Interest coverage
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -340,000 | -280,000 | 54,000 | -124,000 | -88,709 |
| Interest expense | US$ in thousands | 2,000 | 2,000 | 260 | — | — |
| Interest coverage | -170.00 | -140.00 | 207.69 | — | — |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $-340,000K ÷ $2,000K
= -170.00
As the data provided does not include the interest coverage ratios for Arcus Biosciences Inc for the years 2019 to 2023, it is not possible to perform a detailed analysis of the company's interest coverage over this period. Interest coverage ratio is a key financial metric that indicates a company's ability to meet interest obligations on its outstanding debt. A higher interest coverage ratio indicates a stronger ability to cover interest expenses with operating income.
In order to assess Arcus Biosciences Inc's financial health and ability to cover its interest expenses, it would be essential to calculate the interest coverage ratio for each year by dividing operating income by interest expenses. With this information, a trend analysis and comparison with industry benchmarks could provide valuable insights into the company's financial position and its ability to manage its debt effectively.
Peer comparison
Dec 31, 2023